RCE 4.26% 49.0¢ recce pharmaceuticals ltd

Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial, page-5

  1. 589 Posts.
    lightbulb Created with Sketch. 357
    Oh, Recce. You never fail to disappoint. I count three bald-faced lies in just the first two lines of this announcement!
    The Donald Trump of the ASX.

    Lie 1: RCE call it a "Phase I/II" but it is just a phase 1.

    Lie 2: RCE say they have dosed "clinical subjects" but they are dosing healthy subjects.

    Lie 3: They say it's a "UTI/Urosepsis" clinical trial but it's a safety / pharmacokinetics trial.

    Source: Their own trial data
    https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385744
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
49.0¢
Change
0.020(4.26%)
Mkt cap ! $113.4M
Open High Low Value Volume
47.5¢ 50.0¢ 47.5¢ $128.2K 264.6K

Buyers (Bids)

No. Vol. Price($)
1 2061 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.5¢ 9544 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.